Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes
Not Applicable
Completed
- Conditions
- Hodgkin's Lymphoma
- Interventions
- Drug: Escalated BEACOPP
- First Posted Date
- 2011-02-28
- Last Posted Date
- 2015-02-04
- Lead Sponsor
- Cancer Institute WIA
- Target Recruit Count
- 50
- Registration Number
- NCT01304849
- Locations
- 🇮🇳
Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, India
© Copyright 2025. All Rights Reserved by MedPath